United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver FailureBusiness Wire • 01/26/26
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of DirectorsBusiness Wire • 01/22/26
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-TermZacks Investment Research • 01/16/26
United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/05/26
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-TermZacks Investment Research • 12/10/25
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare BaseInvestors Business Daily • 11/21/25
United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/18/25
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-TermZacks Investment Research • 11/12/25
United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal DiseaseBusiness Wire • 11/03/25
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss MarkZacks Investment Research • 10/29/25
Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/29/25